Synaptiq.io, founded in 2020 and headquartered in Romania, is pioneering advancements in the healthcare sector with its innovative approach to cancer treatment. The company's slogan, "Transforming cancer treatment through AI-assisted radiotherapy," encapsulates its mission of leveraging AI technology to improve patient outcomes.
Synaptiq.io's core solution addresses the labor-intensive process of contouring tumors and organs at risk during radiotherapy, traditionally a task requiring up to four hours. Through their sophisticated AI-driven software, this process is optimized and reduced to as little as five minutes, significantly improving efficiency and allowing medical professionals to dedicate more time to patient care.
Operating at the intersection of AI and Health Care, Synaptiq.io remains a compelling prospect for investors by showcasing the tangible impact of technology in medicine. Their most recent funding came in the form of a Grant investment on 06 June 2023, underscoring a growing recognition and support for their mission and innovative solutions.